Endexx Corp (EDXC) 0.0400 $EDXC
NTRR Leadership Travels to Colorado to Strike Product Testing Deals With Cannabis Farmers
Business Wire - Thu Feb 12, 4:00AM CST
Representatives from Neutra Corp. (OTCBB: NTRR) and its joint venture partner, Surface to Air Solutions (S2O2), traveled to Colorado this week seeking out new product testing partnerships with local cannabis farmers.
INSY: 51.50 (-0.66)
GTSO Formulates New Acquisitions Strategy in $2.7 Billion U.S. Cannabis Industry
Business Wire - Mon Feb 09, 8:53AM CST
Green Technology Solutions, Inc. (OTCBB: GTSO) announced today that the company is beginning a new acquisitions campaign to fill out its asset portfolio with new technology products, services and innovations in the $2.7 billion U.S. cannabis industry.
INSY: 51.50 (-0.66)
NTRR Targets Colorado as Ideal Market to Test New Cannabis Cultivation Technology
Business Wire - Mon Feb 09, 8:31AM CST
Neutra Corp. (OTCBB: NTRR), a provider of innovative all-natural wellness solutions, and joint venture partner Surface to Air Solutions (S2O2) are working to build new partnerships with cannabis cultivators in Colorado to test out and demonstrate the company's suite of market-ready agricultural technologies.
INSY: 51.50 (-0.66)
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
NTRR Plans Bold Expansion Into New Nutraceutical Markets With Versatile Inhalation Technology
Business Wire - Thu Feb 05, 4:00AM CST
As Neutra Corp. (OTCBB: NTRR) continues to develop new nutraceutical applications for the Diamond Anvil vapor pen, the company is making plans to expose the innovative product offering to potentially lucrative new global markets beyond the legal cannabis industry.
INSY: 51.50 (-0.66)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Endexx Corporation to Present at Cannabis Investor Webcast
ACCESSWIRE - Wed Jan 28, 3:34PM CST
Cave Creek, AZ / ACCESSWIRE / January 28, 2015 / Endexx Corporation (OTC:EDXC) is a micro-cap publicly traded company, collaborating with independent software developers, scientists, engineers, and other companies to build businesses. Endexx Corporation, will be a presenter at the upcoming Cannabis Investor Webcast on Thursday, January 29, 2015 at 3:00 PM EST.
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Endexx Announces Positive Results of Initial Diabetic Neuropathy Patient Study
Marketwired - Wed Jan 28, 6:01AM CST
Endexx Corporation (OTC PINK: EDXC) announced today that phase 1 of a diabetic neuropathy case study with the purpose of observing if M3CBD, a uniquely formulated CBD and CBD-A rich industrial hemp extract would mitigate or alleviate pain when inhaled through an electronic vaporizer, has been successfully completed. The case study was initiated in late November 2014 by Dr. Daniel Kiddy, as a voluntary patient study.
NTRR Prepares to Deliver New Technologies for the Fastest Growing Industry in the U.S.
Business Wire - Wed Jan 28, 4:00AM CST
As Neutra Corp. (OTCBB: NTRR) and its partners continue to market and develop new products to serve the U.S. cannabis industry, a new report from analysts ArcView Market Research named that rapidly expanding industry as the fastest-growing in the country.
INSY: 51.50 (-0.66)
Endexx Provides Shareholder Update 2014/2015
Marketwired - Tue Jan 06, 7:02PM CST
Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, is pleased to provide a synopsis of 2014 and forward-looking initiatives for 2015.
Endexx Gears Up to Commercialize Dispensing Technology
ACCESSWIRE - Wed Dec 17, 8:01AM CST
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Endexx's Cannsumables Contribute to Diabetic Neuropathy Study
ACCESSWIRE - Wed Dec 10, 8:30AM CST
WHITEFISH, MT / ACCESSWIRE / December 10, 2014 / Endexx Corporation (OTC: EDXC), a provider of medical marijuana management and technology solutions, recently announced that its Cannsumable division would be providing its CBD Starter Kit M3Vape to a voluntary patient study that seeks to determine the effects of industrial hemp oil that is rich in CBD/CBDa on patients suffering from diabetic neuropathy.
Endexx Contributes to Diabetic Neuropathy Case Study
Marketwired - Tue Dec 09, 6:00AM CST
Endexx Corporation (OTC PINK: EDXC) announced today that it is providing its CBD (Cannabidiol) starter kit (M3Vape) to a voluntary patient study utilizing industrial hemp oil that is rich in CBD/CBDa, as an application to potentially alleviate symptoms arising from diabetic neuropathy. Thirteen diabetic patients suffering from neuropathy in Missouri began a 30 day voluntary study in late November under the oversight of Dr. Daniel Kiddy, DPM. Dr. Kiddy stated, "The main objective for this short study is to simply see if pain is decreased or eliminated. We are also monitoring if the proprioception and sharp and dull sensation are improved."
Endexx Launches Marijuana Dispensing Pilot Program in Colorado
Marketwired - Mon Dec 01, 8:25AM CST
Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that the secured site location to test its Autospense(TM) technology is at Pure Medical Marijuana Dispensary on Colfax Ave. in Denver, Colorado. Pure was one of the first two dispensaries in 2009 to become a licensed dispensary in Colorado, and has served as a leader in the medical marijuana market for quality control, technology integration and compliance protocol. The 100-day pilot program is designed to test for compliance and tracking integration under the regulations set forth and enforced by the Marijuana Enforcement Division of Colorado. The pilot program also allows for collaboration in a live dispensary environment, to test technology and process integration for benefit of the dispensary owner and its patients and customers. The Autospense is installed and being calibrated this week for full time use.
NTRR Leadership Travels to Colorado to Strike Product Testing Deals With Cannabis Farmers
Business Wire - Thu Feb 12, 4:00AM CST
Representatives from Neutra Corp. (OTCBB: NTRR) and its joint venture partner, Surface to Air Solutions (S2O2), traveled to Colorado this week seeking out new product testing partnerships with local cannabis farmers.
INSY: 51.50 (-0.66)
GTSO Formulates New Acquisitions Strategy in $2.7 Billion U.S. Cannabis Industry
Business Wire - Mon Feb 09, 8:53AM CST
Green Technology Solutions, Inc. (OTCBB: GTSO) announced today that the company is beginning a new acquisitions campaign to fill out its asset portfolio with new technology products, services and innovations in the $2.7 billion U.S. cannabis industry.
INSY: 51.50 (-0.66)
NTRR Targets Colorado as Ideal Market to Test New Cannabis Cultivation Technology
Business Wire - Mon Feb 09, 8:31AM CST
Neutra Corp. (OTCBB: NTRR), a provider of innovative all-natural wellness solutions, and joint venture partner Surface to Air Solutions (S2O2) are working to build new partnerships with cannabis cultivators in Colorado to test out and demonstrate the company's suite of market-ready agricultural technologies.
INSY: 51.50 (-0.66)
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
NTRR Plans Bold Expansion Into New Nutraceutical Markets With Versatile Inhalation Technology
Business Wire - Thu Feb 05, 4:00AM CST
As Neutra Corp. (OTCBB: NTRR) continues to develop new nutraceutical applications for the Diamond Anvil vapor pen, the company is making plans to expose the innovative product offering to potentially lucrative new global markets beyond the legal cannabis industry.
INSY: 51.50 (-0.66)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Endexx Corporation to Present at Cannabis Investor Webcast
ACCESSWIRE - Wed Jan 28, 3:34PM CST
Cave Creek, AZ / ACCESSWIRE / January 28, 2015 / Endexx Corporation (OTC:EDXC) is a micro-cap publicly traded company, collaborating with independent software developers, scientists, engineers, and other companies to build businesses. Endexx Corporation, will be a presenter at the upcoming Cannabis Investor Webcast on Thursday, January 29, 2015 at 3:00 PM EST.
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
Endexx Announces Positive Results of Initial Diabetic Neuropathy Patient Study
Marketwired - Wed Jan 28, 6:01AM CST
Endexx Corporation (OTC PINK: EDXC) announced today that phase 1 of a diabetic neuropathy case study with the purpose of observing if M3CBD, a uniquely formulated CBD and CBD-A rich industrial hemp extract would mitigate or alleviate pain when inhaled through an electronic vaporizer, has been successfully completed. The case study was initiated in late November 2014 by Dr. Daniel Kiddy, as a voluntary patient study.
NTRR Prepares to Deliver New Technologies for the Fastest Growing Industry in the U.S.
Business Wire - Wed Jan 28, 4:00AM CST
As Neutra Corp. (OTCBB: NTRR) and its partners continue to market and develop new products to serve the U.S. cannabis industry, a new report from analysts ArcView Market Research named that rapidly expanding industry as the fastest-growing in the country.
INSY: 51.50 (-0.66)
Endexx Provides Shareholder Update 2014/2015
Marketwired - Tue Jan 06, 7:02PM CST
Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, is pleased to provide a synopsis of 2014 and forward-looking initiatives for 2015.
Endexx Gears Up to Commercialize Dispensing Technology
ACCESSWIRE - Wed Dec 17, 8:01AM CST
Whitefish, MT / ACCESSWIRE / December 17, 2014 / The idea of an automated marijuana-dispensing machine has been a fantasy of sorts since the cannabis industry's inception. By automating the identification, purchasing, and dispensing processes, dispensaries wouldn't have to worry quite as much about critical issues like security, cash management, or proper identification while the device could certainly help cut down on costs over time.
Endexx's Cannsumables Contribute to Diabetic Neuropathy Study
ACCESSWIRE - Wed Dec 10, 8:30AM CST
WHITEFISH, MT / ACCESSWIRE / December 10, 2014 / Endexx Corporation (OTC: EDXC), a provider of medical marijuana management and technology solutions, recently announced that its Cannsumable division would be providing its CBD Starter Kit M3Vape to a voluntary patient study that seeks to determine the effects of industrial hemp oil that is rich in CBD/CBDa on patients suffering from diabetic neuropathy.
Endexx Contributes to Diabetic Neuropathy Case Study
Marketwired - Tue Dec 09, 6:00AM CST
Endexx Corporation (OTC PINK: EDXC) announced today that it is providing its CBD (Cannabidiol) starter kit (M3Vape) to a voluntary patient study utilizing industrial hemp oil that is rich in CBD/CBDa, as an application to potentially alleviate symptoms arising from diabetic neuropathy. Thirteen diabetic patients suffering from neuropathy in Missouri began a 30 day voluntary study in late November under the oversight of Dr. Daniel Kiddy, DPM. Dr. Kiddy stated, "The main objective for this short study is to simply see if pain is decreased or eliminated. We are also monitoring if the proprioception and sharp and dull sensation are improved."
Endexx Launches Marijuana Dispensing Pilot Program in Colorado
Marketwired - Mon Dec 01, 8:25AM CST
Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that the secured site location to test its Autospense(TM) technology is at Pure Medical Marijuana Dispensary on Colfax Ave. in Denver, Colorado. Pure was one of the first two dispensaries in 2009 to become a licensed dispensary in Colorado, and has served as a leader in the medical marijuana market for quality control, technology integration and compliance protocol. The 100-day pilot program is designed to test for compliance and tracking integration under the regulations set forth and enforced by the Marijuana Enforcement Division of Colorado. The pilot program also allows for collaboration in a live dispensary environment, to test technology and process integration for benefit of the dispensary owner and its patients and customers. The Autospense is installed and being calibrated this week for full time use.
